| Overview |
| bsm-51410M |
| BAIAP2 (4G7) Monoclonal Antibody |
| WB |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Mouse |
| Purified His-tagged BAIAP2 protein was used to produced this monoclonal antibody. |
| Monoclonal |
| 4G7 |
| IgG2b |
| 0.5ug/ul |
| Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, followed by dialysis against PBS. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 10458 |
| Q9UQB8 |
| BAP2; FLAF3; IRSP53; Brain-specific angiogenesis inhibitor 1-associated protein 2; BAI-associated protein 2; BAI1-associated protein 2; Protein BAP2; Fas ligand-associated factor 3; Insulin receptor substrate p53/p58; IRS-58; IRSp53/58; Insulin receptor substrate protein of 53 kDa; Insulin receptor substrate p53; BAIAP2 |
| Adapter protein that links membrane-bound small G-proteins to cytoplasmic effector proteins. Necessary for CDC42-mediated reorganization of the actin cytoskeleton and for RAC1-mediated membrane ruffling. Involved in the regulation of the actin cytoskeleton by WASF family members and the Arp2/3 complex. Plays a role in neurite growth. Acts syngeristically with ENAH to promote filipodia formation. Plays a role in the reorganization of the actin cytoskeleton in response to bacterial infection. Participates in actin bundling when associated with EPS8, promoting filopodial protrusions. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz